The Influence of Cost-Effectiveness Evaluations on Reimbursement in Australia: A Retrospective Study of Decisions made by the Pharmaceutical Benefits Advisory Committee
Crossref DOI link: https://doi.org/10.1007/s40290-014-0063-5
Published Online: 2014-08-05
Published Print: 2014-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ngo, Phuong
Text and Data Mining valid from 2014-08-01